Ensifentrine

CAS: 1884461-72-6 货号: E655682 分子式: C26H31N5O4 分子量: 477.56 EC号: 973-852-2 PubChem CID: 9934746
有货
级别和纯度: 10mM in DMSO
别名
恩替芬特林
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
E655682-1ml
期货 Stock Image
¥4,200.90
请输入您要添加的产品数量

概述


Ensifentrine (RPL-554) is an inhaled first-in-class dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4 with IC 50 s of 0.4 nM and 1479 nM, respectively. Ensifentrine has bronchoprotective and anti-inflammatory activities. Ensifentrine can be used for chronic obstructive pulmonary disease (COPD) research

In Vitro

Ensifentrine (RPL-554) inhibits, in a concentration-dependent manner, lipopolysaccharide-induced TNF-α release from human monocytes (IC 50 of 0.52 μM) and proliferation of human mononuclear cells to phytohemagglutinin (IC 50 of 0.46 μM). Electrical field stimulation-induced contraction of guinea pig superfused isolated tracheal preparations is significantly inhibited by Ensifentrine (10 μM). Contractile responses are suppressed for up to 12 h after termination of superfusion with RPL-554 demonstrating a long duration of action. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Ensifentrine (RPL-554; 10 mg/kg; Oral administration; once) significantly inhibits eosinophil recruitment following antigen challenge in ovalbumin-sensitized guinea pigs . The inhalation of dry powder containing Ensifentrine by conscious guinea pigs (25% in micronized lactose) 1.5 h before antigen exposure significantly inhibits the recruitment of eosinophils to the airways . Exposure of conscious guinea pigs to inhalation of dry powder containing Ensifentrine (2.5%) in micronized lactose significantly inhibits histamine-induced plasma protein extravasation in the trachea and histamine-induced bronchoconstriction over a 5.5-h period . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Dunkin Hartley guinea pigs (200-300 g) injected with ovalbumin . Dosage: 10 mg/kg Administration: Oral administration; once Result: Significantly inhibits eosinophil recruitment following antigen challenge in ovalbumin-sensitized guinea pigs.

IC50& Target:PDE3 0.4 nM (IC 50 ) PDE4 1479 nM (IC 50 )

规格

别名
恩替芬特林
规格或纯度
10mM in DMSO
英文名称
Ensifentrine
生化机理
Ensifentrine(RPL-554)是一种吸入式磷酸二酯酶 3 (PDE3) 和 PDE4 一级双重抑制剂,其 IC 50 s 分别为 0.4 nM 和 1479 nM。Ensifentrine 具有支气管保护和抗炎活性。Ensifentrine 可用于治疗慢性支气管炎。
储存条件
-80℃储存
运输条件
特低温运输
作用类型
抑制剂
名称和识别符
EC号
813-865-1
分子类型
小分子
Isomeric SMILES
CC1=CC(=C(C(=C1)C)N=C2C=C3C4=CC(=C(C=C4CCN3C(=O)N2CCNC(=O)N)OC)OC)C
PubChem CID
MeSH Entry Terms
9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimidino(6,1-a)isoquinolin-4-one;ensifentrine;RPL 554;RPL-554;RPL554
分子量
477.56

高级数据

安全和危险性(GHS)
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器